SEP 01, 2020 8:30 AM PDT

Honeybee venom destroys triple-negative breast cancer cells

New research published in the international journal npj Precision Oncology reports that honeybee venom is capable of killing aggressive triple-negative breast cancer and HER2-enriched breast cancer cells. The study used the venom from 312 honeybees and bumblebees in Perth Western Australia, Ireland and England, determining that both their venom and another compound called melittin can destroy breast cancer cells and act as anticancer agents.

"No-one had previously compared the effects of honeybee venom or melittin across all of the different subtypes of breast cancer and normal cells. We tested honeybee venom on normal breast cells, and cells from the clinical subtypes of breast cancer: hormone receptor-positive, HER2-enriched, and triple-negative breast cancer,” said Dr. Ciara Duffy from the Harry Perkins Institute of Medical Research and The University of Western Australia. "We tested a very small, positively charged peptide in honeybee venom called melittin, which we could reproduce synthetically, and found that the synthetic product mirrored the majority of the anti-cancer effects of honeybee venom.”

Triple-negative breast cancer is known to be one of the most aggressive types of breast cancer and there are limited treatment options for the disease. Dr. Duffy found that venom and the melittin compound offer anti-cancer properties that could be helpful in potential treatments.

"We found both honeybee venom and melittin significantly, selectively and rapidly reduced the viability of triple-negative breast cancer and HER2-enriched breast cancer cells. The venom was extremely potent," Dr. Duffy said. "We found that melittin can completely destroy cancer cell membranes within 60 minutes."

This works because melittin impedes the chemical messages that trigger cancer cell growth and division – all within 20 minutes. "We looked at how honeybee venom and melittin affect the cancer signaling pathways, the chemical messages that are fundamental for cancer cell growth and reproduction, and we found that very quickly these signaling pathways were shut down,” explained Duffy. “Melittin modulated the signaling in breast cancer cells by suppressing the activation of the receptor that is commonly overexpressed in triple-negative breast cancer, the epidermal growth factor receptor, and it suppressed the activation of HER2 which is over-expressed in HER2-enriched breast cancer," she said.

Meanwhile, Dr. Duffy and her team found that another particular concentration of honeybee venom can trigger 100% cancer cell death while simultaneously not affecting healthy cells.

Photo: Pixabay

While further research will need to be conducted in order to determine the best way that melittin and venom could be integrated into cancer treatments, Dr. Duffy’s experiments in mice models show that melittin is effective at reducing tumor growth when paired with chemotherapies, such as docetaxel.

Western Australia's Chief Scientist Professor Peter Klinken said "This is an incredibly exciting observation that melittin, a major component of honeybee venom, can suppress the growth of deadly breast cancer cells, particularly triple-negative breast cancer. Significantly, this study demonstrates how melittin interferes with signaling pathways within breast cancer cells to reduce cell replication. It provides another wonderful example of where compounds in nature can be used to treat human diseases", he said.

Sources: npj Precision Oncology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 17, 2020
Cancer
Are Cancer Exosomes a Good Source of Biomarkers?
AUG 17, 2020
Are Cancer Exosomes a Good Source of Biomarkers?
One of cancer’s most aggravating qualities is its ability to control the microenvironment around it. This control ...
AUG 21, 2020
Cancer
Firefighters risk greater carcinogenic exposure than previously thought
AUG 21, 2020
Firefighters risk greater carcinogenic exposure than previously thought
New research published in the journal Environment International suggests that firefighters may be more exposed to c ...
AUG 31, 2020
Cancer
New hydrogels mimic lymph nodes to proliferate T-cells
AUG 31, 2020
New hydrogels mimic lymph nodes to proliferate T-cells
From a collaboration between cancer researchers and materials science engineers comes a development in the field of hydr ...
SEP 03, 2020
Cancer
Largest study to date on the link between hair dye and cancer
SEP 03, 2020
Largest study to date on the link between hair dye and cancer
A new study published in the British Medical Journal is the largest of its kind to look at the link between hair dy ...
OCT 08, 2020
Cancer
Oral cancer pain levels indicate metastasis
OCT 08, 2020
Oral cancer pain levels indicate metastasis
A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer ex ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
Loading Comments...